February 3, 2023 Lab Top-10 Microscopy Molecular Spectroscopy

Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology

Novel compact, single-story 4 Kelvin 1.0 GHz NMR systems already accepted at RIKEN, Japan and University of Barcelona, Spain in late 2022 ahead of schedule FÄLLANDEN, Switzerland–(BUSINESS WIRE)– Bruker today announced successful customer installations of two novel, compact 1.0 GHzNMR spectrometers for advanced structural and molecular biology applications well ahead of original schedules in late... Read more

February 2, 2023 Environ, Ag./Food & Bev Lab Top-10 Product Launch

Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity

Thermo Fisher’s latest net-zero milestone to be achieved through 200-megawatt solar project WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it will power all of the company’s current U.S. sites with 100 percent renewable electricity by 2026. The company’s new 20-year virtual power purchasing agreement with... Read more

February 1, 2023 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 Highlights Fourth quarter revenue grew 7% to $11.45 billion. Fourth quarter GAAP diluted earnings per share (EPS) was... Read more

January 31, 2023 Lab Top-10 Life Science Tools PR/Corporate

Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the... Read more

January 24, 2023 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports Fourth Quarter and Full Year 2022 Results

WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022.  All results in this release reflect only continuing operations unless otherwise noted.  Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more

January 5, 2023 Lab Top-10

Bruker Announces Acquisition of ACQUIFER Imaging GmbH

Adding Big-Data Management and High-Content Screening Solutions for Bioimaging Applications HEIDELBERG, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products,... Read more

January 4, 2023 Lab Top-10

Thermo Fisher Scientific to Present at 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. (EST). You can access the webcast of the presentation via the... Read more

January 4, 2023 Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics M&A, Partnerships Other Lab Products/Services

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more